E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/24/2004 in the Prospect News PIPE Daily.

New Issue: Resverlogix wraps downsized private placement for C$7.9 million

By Sheri Kasprzak

Atlanta, Nov. 24 - Resverlogix Corp. said Wednesday it has wrapped up a private placement for C$7.9 million, downsized from the originally announced C$9 million offering.

The company sold 2,639,633 shares at C$3 per share.

First Associates Investments Inc. was lead agent in the deal with a syndicate that included Haywood Securities Inc., Sprott Securities Inc. and Jennings Capital Inc.

The offering was first announced Oct. 6 as a C$9 million deal.

Resverlogix, based in Calgary, Alta., is a biotechnology company focused on the development of biopharmaceuticals.

Issuer:Resverlogix Corp.
Issue:Stock
Amount:C$7.9 million
Shares:2,639,633
Price:C$3
Warrants:No
Placement agent:First Associates Investments Inc. (lead); Haywood Securities Inc.; Sprott Securities Inc.; Jennings Capital Inc.
Announcement date:Oct. 6
Settlement date:Nov. 24
Stock price:C$3.65 at close Oct. 6
Stock price:C$3.35 at close Nov. 24

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.